Cellular interleukin‐1 receptor antagonist production in patients receiving on‐line haemodiafiltration therapy
Bernard Canaud(Université de Montpellier), D. Falkenhagen, G. Schultze(Nephrologisches Zentrum Villingen-Schwenningen), Roger Greenwood(Mount Sinai Beth Israel), Francesco Pizzarelli(Azienda Ospedale - Università Padova), Christoph Weber(Eppendorf (Germany)), V. Wizemann(PHV Dialysezentrum)
Cited by 60
Related Papers
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
Vascular access use in Europe and the United States: Results from the DOPPS
|Kidney International|2002|855
Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)
|Nephrology Dialysis Transplantation|2003|472
Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS
|Kidney International|2006|453
Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy
|Nephrology Dialysis Transplantation|2010|426